Amanote Research

Amanote Research

    RegisterSign In

Recombinant and Chimeric Disintegrins in Preclinical Research

Toxins - Switzerland
doi 10.3390/toxins10080321
Full Text
Open PDF
Abstract

Available in full text

Categories
MutagenesisToxicologyHealth
Date

August 7, 2018

Authors
Victor DavidBarbara Barbosa SuccarJoão Alfredo de MoraesRoberta Ferreira Gomes Saldanha-GamaChristina Barja-FidalgoRussolina Benedeta Zingali
Publisher

MDPI AG


Related search

Reporting of Preclinical Research in ANESTHESIOLOGY

Anesthesiology
AnesthesiologyPain Medicine
2016English

Preclinical Stroke Research: Gains and Gaps

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2013English

Quetiapine: Recent Developments in Preclinical Research

Clinical Management Issues
MedicineAccountingManagementBusiness
2010English

Preclinical Research: Meet Patients to Sharpen Up Research

Nature
Multidisciplinary
2017English

Recent Progress in Preclinical HIV-1 Vaccine Research

2019English

Immunogenicity and Antigenicity of a Recombinant Chimeric Protein Containing Epitopes of Poliovirus Type 1

Acta Virologica
MedicineVirologyInfectious Diseases
2016English

Preclinical Research: A Rise or Dawn

Pharmacy & Pharmacology International Journal
2018English

Preclinical Assessment of FHIT Gene Replacement Therapy in Human Leukemia Using a Chimeric Adenovirus, Ad5/F35

Clinical Cancer Research
Cancer ResearchOncology
2006English

A Plant-Derived Recombinant Human Glucocerebrosidase Enzyme—A Preclinical and Phase I Investigation

PLoS ONE
Multidisciplinary
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy